The Chemours Company, founded in 2015 and headquartered in the United States, positions itself as a global leader in the Medical Devices industry, delivering on its commitment to "Delivering trusted chemistry that the world needs."
The company excels in industrial and specialty chemicals, catering to crucial sectors such as high-performance computing, AI, advanced electronics, and transportation solutions including electric and low-emission vehicles. Its innovative solutions are organized across three core businesses: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.
Chemours markets several prominent chemical brands including Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. The company recently secured a significant $600.00M Post-IPO Debt investment, signaling robust investor confidence in its growth prospects and operational stability.